American Heart Journal
Volume 135, Issue 5 , Pages 833-837 , May 1998

Alcohol consumption and idiopathic dilated cardiomyopathy: A case control study

Received 21 March 1997 ,Accepted 18 December 1997.

References 

  1. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J. 1980;44:672–673
  2. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Circulation. 1996;93:841–842
  3. Schwartz F, Mall G, Zebe H, et al.  Determinants of survival in patients with congestive cardiomyopathy: quantitative morphologic findings and left ventricular hemodynamics. Circulation. 1984;70:923–929
  4. Fuster V, Gersh BJ, Giuliani ER, et al.  The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol. 1981;47:525–531
  5. Komajda M, Richard JL, Bouhour JB, et al.  Dilated cardiomyopathy and the level of alcohol consumption: a planned multicentre case-control study. Eur Heart J. 1986;7:512–519
  6. Gillet C, Juilliere Y, Pirollet P, et al.  Alcohol consumption and biological markers for alcoholism in idiopathic dilated cardiomyopathy: a case-controlled study. Alcohol Alcohol. 1992;27:353–358
  7. Henry WL, Gardin JM, Ware JH. Echocardiographic measurements in normal subjects from infancy to old age. Circulation. 1980;62:1054–1061
  8. Whelan BJ. RANSAM: a random sample design for Ireland. Econ Soc Review. 1979;10:169–174
  9. Mayfield D, McLeod G, Hall P. The CAGE questionnaire: a validation of a new alcoholism screening instrument. Am J Psychiat. 1974;131:1121–1123
  10. Bernadt MW, Mumford J, Taylor C, Smith B, Murray RM. Comparison of questionnaire and laboratory tests in the detection of excessive drinking and alcoholism. Lancet. 1982;1:325–328
  11. Urbano-Marquez A, Estruch R, Navarro-Lopex F, Grau J, Mont L, Rubin E. The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med. 1989;320:409–415
  12. Matthews EC, Gardin JM, Henry WL, et al.  Echocardiographic abnormalities in chronic alcoholics with and without heart failure. Am J Cardiol. 1981;47:570–578
  13. Regan TJ, Levinson GE, Oldewurtel HA, Frank MJ, Weisse AB, Moschos CB. Ventricular function in noncardiacs with alcoholic fatty liver: the role of ethanol in the production of cardiomyopathy. J Clin Invest. 1969;48:397–407
  14. Pavan D, Nicolosi GL, Lestuzzi C, Burrelli C, Zardo F, Zanuttini D. Normalization of variables of left ventricular function in patients with alcoholic cardiomyopathy after cessation of excessive alcohol intake: an echocardiographic study. Eur Heart J. 1987;8:535–540
  15. Teragaki M, Takeuchi K, Takeda T. Clinical and histological features of alcohol drinkers with congestive heart failure. Am Heart J. 1993;125:808–817
  16. Agatston AS, Snow ME, Samet P. Regression of severe alcoholic cardiomyopathy after abstinence of 10 weeks. Alcoholism. 1986;10:386–387
  17. Regan TJ. Alcohol and the cardiovascular system. JAMA. 1990;264:377–381
  18. Guarnieri T, Lakatta EG. Mechanism of myocardial contractile depression by clinical concentrations of ethanol: a study in ferret papillary muscles. J Clin Invest. 1990;85:1462–1467
  19. Schreiber SS, Briden J, Oratz M, Rothschild M. Ethanol, acetaldehyde and myocardial protein synthesis. J Clin Invest. 1972;51:2820–2826
  20. Puszkin S, Rubin E. Adenosine diphosphate effect on contractility of human muscle actomyosin: inhibition by ethanol and acetaldehyde. Science. 1975;188:1319–1320
  21. Swartz MH, Repke DI, Katz AM, et al.  Effects of ethanol on calcium binding and calcium uptake by cardiac microsomes. Biochem Pharmacol. 1974;23:2369–2376
  22. Williams JW, Tada M, Katz , et al.  Effect of ethanol and acetaldehyde on the (Na + K)-activated adenosine triphosphatase activity of cardiac plasma membranes. Biochem Pharmacol. 1975;24:27–32
  23. Keeling PJ, Gang Y, Smith G, et al.  Familial dilated cardiomyopathy in the United Kingdom. Br Heart J. 1995;73:417–421
  24. Goerss JB, Michels VV, Burnett JB, et al.  Frequency of familial dilated cardiomyopathy. Eur Heart J. 1995;16:2S–4S
  25. Day CP, Bashir R, James OF, et al.  Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol-related end-organ damage. Hepatology. 1991;14:798–801
  26. Weiner FR, Eskreis DS, Compton KV, Orrego H, Zern MA. Halotype analysis of a type I collagen gene and its association with alcoholic cirrhosis in man. Mol Aspects Med. 1988;10:159–168

☆ From the Departments of aClinical cardiology and bEpidemiology and Biostatistics, National Cardiac Centre, Mater Misericordiae Hospital.

☆☆ Reprint requests: C.J. McKenna, MD, Research Fellow, Cardiovascular Diseases, Mayo Clinic, 200 First St. SW, Rochester, MN 55905.

★ 0002-8703/98/$5.00 + 0 4/1/88452

PII: S0002-8703(98)70042-0

American Heart Journal
Volume 135, Issue 5 , Pages 833-837 , May 1998

Article Tools